Prenatal Care & Counseling Issues
... should be made at the first antenatal visit to determine body mass index, which is the basis for recommended weight gain in pregnancy ...
... should be made at the first antenatal visit to determine body mass index, which is the basis for recommended weight gain in pregnancy ...
TB and HIV - I-Tech
... a) Increase dose of NVP to 400 mg bid b) Continue standard dose NVP (200 bid) with close monitoring for treatment failure, and possible increased risk of hepatotoxicity c) Stop ART; resume ART after intensive phase is ...
... a) Increase dose of NVP to 400 mg bid b) Continue standard dose NVP (200 bid) with close monitoring for treatment failure, and possible increased risk of hepatotoxicity c) Stop ART; resume ART after intensive phase is ...
Eliminating Perinatal HIV Transmission
... combination therapy is the standard of care ● In consultation with an HIV expert, start as soon as possible, including in 1st trimester ● Consult data on specific ARVs in pregnancy ...
... combination therapy is the standard of care ● In consultation with an HIV expert, start as soon as possible, including in 1st trimester ● Consult data on specific ARVs in pregnancy ...
Pregnancy Fact Sheet - Crohn`s and Colitis Foundation of America
... taking prescribed medications. Many IBD medications have been shown to cause minimal risk to the pregnancy (see Medications section below). Women with IBD usually have healthy pregnancies and infants. However, they are more likely to have a complication of pregnancy (such as miscarriage, premature d ...
... taking prescribed medications. Many IBD medications have been shown to cause minimal risk to the pregnancy (see Medications section below). Women with IBD usually have healthy pregnancies and infants. However, they are more likely to have a complication of pregnancy (such as miscarriage, premature d ...
Community medicine (4) MCH (part 2) Dr. Huda Adnan 2014
... • Excessive amniotic fluid. • Heamoglobin < 11 gm / dI. • Rh negative. • Vaginal bleeding in early pregnancy. • Third trimester vaginal bleeding. • Rubella exposure. IV. Natal Care “Normal delivery is defined as a process of delivery of a single fetus and other products of conception within 24 hours ...
... • Excessive amniotic fluid. • Heamoglobin < 11 gm / dI. • Rh negative. • Vaginal bleeding in early pregnancy. • Third trimester vaginal bleeding. • Rubella exposure. IV. Natal Care “Normal delivery is defined as a process of delivery of a single fetus and other products of conception within 24 hours ...
application of rule based reasoning system for council hiv
... Economic and social impacts of HIV/AIDS in Ethiopia have not been comprehensively quantified, they are significant and growing. By undermining major determinants of economic growth and preventing increasing segments of the population from participating in the economy, HIV/AIDS increases poverty, dra ...
... Economic and social impacts of HIV/AIDS in Ethiopia have not been comprehensively quantified, they are significant and growing. By undermining major determinants of economic growth and preventing increasing segments of the population from participating in the economy, HIV/AIDS increases poverty, dra ...
Prenatal Care .
... Health of Fetus Females must be very careful about what they take into their body ...
... Health of Fetus Females must be very careful about what they take into their body ...
Step 1 Provide immediate care to the exposure site
... substitute for face-to-face counseling, resource should be available to provide immediate evaluation and follow-up care for all exposures. • The designation “consider PEP” indicates that PEP is optional and should be based on as individualized decision between the exposed person and the treating cli ...
... substitute for face-to-face counseling, resource should be available to provide immediate evaluation and follow-up care for all exposures. • The designation “consider PEP” indicates that PEP is optional and should be based on as individualized decision between the exposed person and the treating cli ...
Medical Evaluation of the HIV Dental Patient
... • Dental management of HIV infected patients does not differ from that of non-HIV infected patients. Most treatment can be performed by general practitioners. No special facility or equipment is required. “Standard Precautions” are followed. • HIV infected patients who require specialist care shoul ...
... • Dental management of HIV infected patients does not differ from that of non-HIV infected patients. Most treatment can be performed by general practitioners. No special facility or equipment is required. “Standard Precautions” are followed. • HIV infected patients who require specialist care shoul ...
Medical Evaluation of the HIV Dental Patient
... • Dental management of HIV infected patients does not differ from that of non-HIV infected patients. Most treatment can be performed by general practitioners. No special facility or equipment is required. “Standard Precautions” are followed. • HIV infected patients who require specialist care shoul ...
... • Dental management of HIV infected patients does not differ from that of non-HIV infected patients. Most treatment can be performed by general practitioners. No special facility or equipment is required. “Standard Precautions” are followed. • HIV infected patients who require specialist care shoul ...
IOSR Journal of Pharmacy and Biological Sciences (IOSR-JPBS)
... Primary HIV infection: May be either asymptomatic or associated with acute retroviral syndrome. Stage I: HIV infection is asymptomatic with a CD4+ T cell count (also known as CD4 count) greater than 500 per micro liter (µl or cubic mm) of blood. May include generalized lymph node enlargement. ...
... Primary HIV infection: May be either asymptomatic or associated with acute retroviral syndrome. Stage I: HIV infection is asymptomatic with a CD4+ T cell count (also known as CD4 count) greater than 500 per micro liter (µl or cubic mm) of blood. May include generalized lymph node enlargement. ...
IOSR Journal Of Humanities And Social Science (IOSR-JHSS)
... extent but non-adherence has occurred as vital barrier in the management of HIV. The present study aiming at understanding the factors causing non-adherence in antiretroviral treatment is a summary of eight focus group discussions held with PLHIVs (People living with HIV) in selected hospitals of De ...
... extent but non-adherence has occurred as vital barrier in the management of HIV. The present study aiming at understanding the factors causing non-adherence in antiretroviral treatment is a summary of eight focus group discussions held with PLHIVs (People living with HIV) in selected hospitals of De ...
Post-Exposure Prophylaxis after Non-Occupational
... Prescribing PEP Ultimately, the decision to prescribe PEP needs to be made on a case-by-case basis considering all the variables. These guidelines are not prescriptive, but put forward cases where PEP is recommended and the benefit of treatment is likely to exceed harm. Situations where there is gr ...
... Prescribing PEP Ultimately, the decision to prescribe PEP needs to be made on a case-by-case basis considering all the variables. These guidelines are not prescriptive, but put forward cases where PEP is recommended and the benefit of treatment is likely to exceed harm. Situations where there is gr ...
Powerpoint
... • ART: 1 RCT in naive HIV-infected children found no difference in adverse events comparing AZT+3TC and ABC+3TC • Other considerations: Availability of age-appropriate formulations and alignment with adopted 1st line ART in countries, side-effect profile in the context of short-term exposure in HIV- ...
... • ART: 1 RCT in naive HIV-infected children found no difference in adverse events comparing AZT+3TC and ABC+3TC • Other considerations: Availability of age-appropriate formulations and alignment with adopted 1st line ART in countries, side-effect profile in the context of short-term exposure in HIV- ...
What is HIV?
... Drugs used for treatment include antiretroviral drugs(抗 逆转录病毒药) and fusion inhibitors(膜融合抑制剂). Antiretroviral drugs slow down the growth and reproduction of HIV. Fusion inhibitors stop the virus from reproducing(复制) by preventing its membrane(膜 ) from fusing with the membrane of the CD4 lymphocyte ...
... Drugs used for treatment include antiretroviral drugs(抗 逆转录病毒药) and fusion inhibitors(膜融合抑制剂). Antiretroviral drugs slow down the growth and reproduction of HIV. Fusion inhibitors stop the virus from reproducing(复制) by preventing its membrane(膜 ) from fusing with the membrane of the CD4 lymphocyte ...
HIV Epidemiology, Testing Strategies, and Prevention - IAS-USA
... 327/µL (P < .01), with increases seen in all risk groups. Although the proportion of persons with a CD4+ cell count of at least 350/µL at first presentation also increased (34% vs 47%; P = .01), more than half of HIV-infected persons in these cohorts did not present until their CD4+ count was below ...
... 327/µL (P < .01), with increases seen in all risk groups. Although the proportion of persons with a CD4+ cell count of at least 350/µL at first presentation also increased (34% vs 47%; P = .01), more than half of HIV-infected persons in these cohorts did not present until their CD4+ count was below ...
Standard Precautions
... In clinical areas the risk of infection and cross infection are ever present and all precautions must be taken to minimise risk. Controlling infection is everyone’s responsibility. Endogenous - patient’s skin Exogenous - contact with other sources Environmental - inanimate contact Have to be ...
... In clinical areas the risk of infection and cross infection are ever present and all precautions must be taken to minimise risk. Controlling infection is everyone’s responsibility. Endogenous - patient’s skin Exogenous - contact with other sources Environmental - inanimate contact Have to be ...
AIDS Drugs Should Not be Patented
... DATA to raise awareness and money for The Global Fund by teaming up with the world's most iconic brands to produce (PRODUCT)RED branded products. A percentage of each (PRODUCT)RED product sold is given to The Global Fund. The money helps women and children affected by HIV/AIDS in Africa. ...
... DATA to raise awareness and money for The Global Fund by teaming up with the world's most iconic brands to produce (PRODUCT)RED branded products. A percentage of each (PRODUCT)RED product sold is given to The Global Fund. The money helps women and children affected by HIV/AIDS in Africa. ...
Home | Creativ
... be mitochondrial toxicity occurring as a side effect of certain HIV medications. These drugs, primarily zidovudine (AZT), stavudine (D4T) and didanosine (ddI), belong to the nucleoside reverse transcriptase inhibitor (NRTI) class and were among the first agents available to treat HIV. Therefore, pat ...
... be mitochondrial toxicity occurring as a side effect of certain HIV medications. These drugs, primarily zidovudine (AZT), stavudine (D4T) and didanosine (ddI), belong to the nucleoside reverse transcriptase inhibitor (NRTI) class and were among the first agents available to treat HIV. Therefore, pat ...
Adolescent Conference - Society for Adolescent Health in Uganda
... • Pregnant adolescents should be encouraged to attend ANC with older mothers and come back to the adolescent clinic after birth until they get to age of transition ...
... • Pregnant adolescents should be encouraged to attend ANC with older mothers and come back to the adolescent clinic after birth until they get to age of transition ...
Available Guidelines HIV Treatment Guidelines
... • New regimen selection is based on cause of regimen failure and remaining antiretroviral options ...
... • New regimen selection is based on cause of regimen failure and remaining antiretroviral options ...
Bloodborne Pathogens
... employees after an incident where blood or OPIM is present • Division’s procedure in offering vaccinations • May decline vaccine (but must sign waiver) • May receive vaccine later ...
... employees after an incident where blood or OPIM is present • Division’s procedure in offering vaccinations • May decline vaccine (but must sign waiver) • May receive vaccine later ...
Day3Session3-HIV Counselling
... Disclosure of positive HIV test results to partners The need for disclosure to partners- injecting or sexual is important to prevent onward transmission, re infection and infection of newer strain of HIV. This is a complex process and requires a very sensitive approach. Counsellors should support ...
... Disclosure of positive HIV test results to partners The need for disclosure to partners- injecting or sexual is important to prevent onward transmission, re infection and infection of newer strain of HIV. This is a complex process and requires a very sensitive approach. Counsellors should support ...